相关产品推荐更多 >

CXCL1 Polyclonal Antibody(多克隆抗体), HRP conjugated | CXCL1 Antibody, HRP conjugated | CXCL1抗体, HRP conjugated
¥880
TAGLN Polyclonal Antibody(多克隆抗体) | TAGLN Antibody | TAGLN抗体
¥3900
SMPD3 Polyclonal Antibody(多克隆抗体), HRP conjugated | SMPD3 Antibody, HRP conjugated | SMPD3抗体, HRP conjugated
¥880
HOXC9 Polyclonal Antibody(多克隆抗体), FITC conjugated | HOXC9 Antibody, FITC conjugated | HOXC9抗体, FITC conjugated
¥880
EIF2AK2 Polyclonal Antibody(多克隆抗体), HRP conjugated | EIF2AK2 Antibody, HRP conjugated | EIF2AK2抗体, HRP conjugated
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
-20°C
- 克隆性:
单克隆
- 适应物种:
Staphylococcus aureus
- 保质期:
12 months
- 级别:
一抗
- 供应商:
武汉研升生物科技有限公司
- 宿主:
Human
- 应用范围:
ELISA, Functional assay, Research in vivo
- 抗体英文名:
Research Grade Anti-ClfA Antibody (AZD7745)
- 规格:
100μg/1mg
| 规格: | 100μg | 产品价格: | ¥2288.0 |
|---|---|---|---|
| 规格: | 1mg | 产品价格: | ¥9188.0 |
| 产品名 | Research Grade Anti-ClfA Antibody (AZD7745) |
| 货号 | JN060026 |
| 别名 | SAR114 |
| 靶标 | Clumping factor A, Fibrinogen receptor A, Fibrinogen-binding protein A, clfA |
| Accession号 | Q53653, Q2G015, Q5HHM8 |
| 宿主 | Human |
| 种属反应性 | Staphylococcus aureus |
| 克隆性 | Monoclonal |
| 克隆号 | AZD7745 |
| 同种型 | IgG |
| 内毒素水平 | < 1EU/mg |
| 纯度 | >95% as determined by SDS-PAGE. |
| 应用 | ELISA, Functional assay, Research in vivo |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4 |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 说明 | For research use only. Not suitable for clinical or therapeutic use. |

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验).8. Block with 4% BSA in TBST for 45 - 60 minutes. I use RIA grade BSA from USB (United States Biochemical; Catalog number 10868). I also include 0.02% NaN3 in this block and reuse it at least 5 times (Keep in 4oC between uses). We have had problems
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
both at transcriptional or posttranscriptional levels (8 -10 ). Recombinant fusion proteins consisting of various bacterial toxins selectively targeted to the tumor by virtue of single-chain anti-erbB- 2 antibody (sFv) moieties has also been utilized in this context (7 ).
技术资料暂无技术资料 索取技术资料





